Cellular mechanisms of lymphocyte-mediated lysis of tumor cells
- PMID: 2151107
Cellular mechanisms of lymphocyte-mediated lysis of tumor cells
Abstract
Both branches, humoral and cellular, of the immune response have specialized mechanisms to lyse tumor cells, virus-infected cells and other targets. The effector components of the humoral response are antibodies and complement, while cytotoxic T lymphocytes (CTL) and natural killer (NK) cells are among the potent effector agents of the cell-mediated immune response. The past few years have witnessed remarkable progress in defining the effector molecules and mechanisms involved in lymphocyte-mediated killing. The recognition of target cells by CTL is antigen specific and restricted through the major histocompatibility complex (MHC). The molecular structure involved in the recognition function is the T cell receptor (TCR), associated with CD3 polypeptides. Conversely, the activity of NK cells in non antigen specific and non MHC restricted. Several surface molecules of cytotoxic lymphocytes have been identified as adhesion-mediating structures. A particular role seems to be played by a family of molecules named lymphocyte function-associated antigens (LFA) and by CD2, CD4 and CD8 antigens. Once the binding between effector and target cell has occurred, a cascade of events can be triggered leading the killer lymphocyte to deliver the lethal hit against the target cell. At least two categories of cytolytic molecules are produced by CTL and NK cells. Perforin is a protein stored in the cytoplasmic granules which forms pores in the plasma membrane of target cell leading to osmotic lysis. The other category of cytolytic factors is the group of soluble mediators which includes lymphotoxin (LT), tumor necrosis factor (TNF) and NK cytotoxic factor (NKCF). Their exact mechanism of action is presently unclear. Several cellular components are involved in the cytolytic mechanism. In particular, the cytoplasmic granules which, upon activation, release a number of cytotoxic factors by directed exocytosis and the cytoskeletal components which, modifying their organization, participate in the binding and killing processes. A growing body of evidence has recently supplied proof that target cells may play an active role in their own lysis supporting the challenging opinion of an induced suicide mechanism.
Similar articles
-
Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.J Immunol. 1992 Jan 1;148(1):55-62. J Immunol. 1992. PMID: 1345790
-
Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.J Immunol. 1989 Sep 1;143(5):1453-60. J Immunol. 1989. PMID: 2503557
-
Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.J Immunol. 1991 May 1;146(9):3242-9. J Immunol. 1991. PMID: 1673149
-
Mechanisms of lymphocyte-mediated lysis.J Cell Biochem. 1989 Mar;39(3):239-52. doi: 10.1002/jcb.240390304. J Cell Biochem. 1989. PMID: 2651463 Review.
-
Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.Fed Proc. 1986 Nov;45(12):2823-8. Fed Proc. 1986. PMID: 3095151 Review.
Cited by
-
Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: strategies to overcome resistance.Semin Oncol. 2014 Oct;41(5):667-77. doi: 10.1053/j.seminoncol.2014.08.006. Epub 2014 Aug 12. Semin Oncol. 2014. PMID: 25440611 Free PMC article. Review.
-
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.Cancer Immunol Immunother. 2013 Aug;62(8):1359-68. doi: 10.1007/s00262-013-1439-1. Epub 2013 May 21. Cancer Immunol Immunother. 2013. PMID: 23689729 Free PMC article.
-
Pregnancy imparts distinct systemic adaptive immune function.Am J Reprod Immunol. 2022 Nov;88(5):e13606. doi: 10.1111/aji.13606. Epub 2022 Sep 6. Am J Reprod Immunol. 2022. PMID: 35989229 Free PMC article.
-
Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.J Clin Med. 2019 Aug 20;8(8):1261. doi: 10.3390/jcm8081261. J Clin Med. 2019. PMID: 31434267 Free PMC article. Review.
-
Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.Cancer Immunol Immunother. 1994 Oct;39(4):254-62. doi: 10.1007/BF01525989. Cancer Immunol Immunother. 1994. PMID: 7525059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous